Women's Health Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Columbia University, New York
Older women treated with anthracyclines show increased risk of cardiomyopathy
February 5th, 2006
Older women show an increased risk of cardiomyopathy when treated with anthracyclines. "Adjuvant chemotherapy, especially with anthracyclines, is known to cause acute and chronic cardiotoxicity in breast cancer patients." Scientists in the United States stated, "We studied the cardiac effects of chemotherapy in a population-based sample of breast cancer patients aged {{>=}}65 years with long-term follow-up." "In the Surveillance, Epidemiology, and End Results (SEER)-Medicare database, we analyzed treatments and outcomes among women {{>=}}65 years of age who were diagnosed with stage I to III breast cancer from January 1, 1992 to December 31,...
Source: Women's Health Law Weekly (2006-02-05)
|
